Mortality in renal transplant recipients given erythropoietins to increase haemoglobin concentration: Cohort study

BMJ (Online)

Volumn 339, Issue 7728, 2009, Pages 1018-

  Heinze, Georg ^a   Kainz, Alexander ^a   Hörl, Walter H ^a   Oberbauer, Rainer ^a,b,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Austrian Dialysis and Transplant Registry   (Austria)

^c KH Elisabethinen ^*  (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN;

ADULT; ALGORITHM; ANEMIA; ARTICLE; AUSTRIA; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIALYSIS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; REGISTER; RETROSPECTIVE STUDY; SURVIVAL TIME;

ANEMIA; CHRONIC DISEASE; ERYTHROPOIETIN; FEMALE; HEMATINICS; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; QUALITY OF LIFE; RECOMBINANT PROTEINS; RENAL DIALYSIS; RETROSPECTIVE STUDIES;

EID: 70350532869     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b4018     Document Type: Article

References (26)

1. Vanrenterghem Y, Ponticelli C, Morales JM, Abramowicz D, Baboolal K, Eklund B, et al. Prevalence and management of anemia in renal transplant recipients: a European survey. Am J Transplant 2003;3:835-845
2. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006;355:2085-2098
3. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia.N Engl J Med 2006;355:2071-2084
4. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl JMed 1998;339:584-590
5. Besarab A, Goodkin DA, Nissenson AR. The normal hematocrit study - follow-up. N Engl JMed 2008;358:433-434
6. Henke M, Laszig R, Rube C, Schafer U, Haase KD, Schilcher B, et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial. Lancet 2003;362:1255-1260 (Pubitemid 37324251)
7. Overgaard J, Hoff C, Sand Hansen H, Specht L, Overgaard M, Grau C, et al. Randomized study of the importance of novel erythropoiesis stimulating protein (Aranesp) for the effect of radiotherapy in patientswith primary squamous cell carcinoma of the head and neck HNSCC) - the Danish Head and Neck Cancer Group DAHANCA 10 randomized trial. Eur J Cancer Suppl 2007;5:7.
8. Leyland-Jones B, Semiglazov V, Pawlicki M, Pienkowski T, Tjulandin S, Manikhas G, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005;23:5960-5972 (Pubitemid 46300213)
9. Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 1989;111:992-1000.
10. Solez K, Axelsen RA, Benediktsson H, Burdick JF, Cohen AH, Colvin RB, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993;44:411-422 (Pubitemid 23228698)
11. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999;55:713-723 (Pubitemid 29082898)
12. Churg J, Sobin LH. Benign nephrosclerosis. In: Churg J, ed. Renal disease - classification and atlas of glomerular diseases. Tokyo: Igaku-Shoin, 1982:211-224
13. Snappin S, Jiang Q, Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimator. Am Stat 2005;59:301-307 (Pubitemid 41616828)
14. Cox DR. Regression models and life-tables. J Royal Stat Soc B 1972;34:187-220.
15. Heinzl H, Kaider A. Gaining more flexibility in Cox proportional hazards regression models with cubic spline functions. Comput Methods Programs Biomed 1997;54:201-208 (Pubitemid 27496007)
16. Hosmer DW, Lemeshow S. Applied survival analysis. Regression modeling of time to event data. New York, NY: Wiley, 1999.
17. Rubin DB. Multiple imputation for nonresponse in surveys. New York, NY: Wiley, 1987.
18. Benyamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 1995;57:289-300.
19. Winkelmayer WC, Chandraker A. Posttransplantation anemia: management and rationale. Clin J Am Soc Nephrol 2008;3:S49-55.
20. Winkelmayer WC, Kewalramani R, Rutstein M, Gabardi S, Vonvisger T, Chandraker A. Pharmacoepidemiology of anemia in kidney transplant recipients. J Am Soc Nephrol 2004;15:1347-1352
21. Kamar N, Rostaing L. Negative impact of one-year anemia on long-term patient and graft survival in kidney transplant patients receiving calcineurin inhibitors and mycophenolate mofetil. Transplantation 2008;85:1120-1124 (Pubitemid 351590189)
22. Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G, et al. Anemia is associated with mortality in kidney-transplanted patients - a prospective cohort study. Am J Transplant 2007;7:818-824 (Pubitemid 46481205)
23. Lorenz M, Kletzmayr J, Perschl A, Furrer A, Horl WH, Sunder-Plassmann G. Anemia and iron deficiencies among long-term renal transplant recipients. J Am Soc Nephrol 2002;13:794-797 (Pubitemid 34183948)
24. Hernan MA, Brumback B, Robins JM. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 2000;11:561-570 (Pubitemid 30660035)
25. Singh AK. The controversy surrounding hemoglobin and erythropoiesis- stimulating agents: what should we do now? Am J Kidney Dis 2008;52(6 suppl):S5-13.
26. Brown ER, Ibrahim JG, DeGruttola V. A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 2005;61:64-73. (Pubitemid 40380965)